Drug Discovery World

MARCH 8, 2023

The Council will explore common challenges at a grassroots level and seed ideas for new pre-competitive projects aligned with the Alliance’s strategic themes: Emerging Sciences and Technology, Improving the Efficiency and Effectiveness of R&D, and Empowering the Patient. The 13 members are: Alex Villalobos, Sr.

Life Science 52

Life Science Bioassay Scientist Research 52

Drug Discovery World

FEBRUARY 23, 2023

Kristen Hopson , Vice President of Preclinical Discovery and Development at Generate Biomedicines, and Yup Liu , Associate Director, HTS at Generate Biomedicines, reflect on the impact of AI, ML cloud computing, and advances in laboratory automation and high-throughput screening (HTS) on life science research.

Protein 52

Protein Life Science Bioassay Development 52

Drug Discovery World

JANUARY 19, 2023

Cell engineering is bringing life science into a new era of biotherapeutic discovery and development, disease modelling, and synthetic biology research. Sphere Fluidics’ Cyto-Mine ® system offers a streamlined, automated solution to this challenge using picodroplet microfluidic technology.

Engineer 52

Engineer Bioassay Life Science Genome 52

Drug Discovery World

NOVEMBER 9, 2023

Advances in analytical techniques and approaches This session is made up of four presentations which include: Christian Graf, PhD, Fellow, Scientific Office, Novartis TRD Biologics, on: ‘MS-based cell bioassays: A novel tool for biotherapeutics characterisation’. Crystal Richardson, Ph.D, Patrick Doonan, Ph.D.,

Engineer 52

Engineer Antibody Protein In-Vivo 52

Drug Discovery World

NOVEMBER 30, 2023

Promega had two posters from which to share insight, which included: ‘Cell-based luminescent reporter bioassays for immunotherapies targeting macrophage effector functions’, and ‘Development of bioluminescent no-wash Fc gamma receptor binding immunoassay to guide the development of antibody therapeutics’.

Antibody 59

Antibody Protein Engineer In-Vivo 59